Boost for the innovative digital therapy solution for patients with chronic respiratory diseases

Garching, May 21, 2019 – The Munich based start-up VisionHealth received a grant with the renowned SME funding from the EU’s Horizon 2020 research and innovation program. The pioneer in digital therapy supports patients with chronic respiratory diseases (CRD).

Small and medium-sized enterprises (SME) which are based in one of the EU’s member states, or are established in a Horizon 2020 associated country, can receive EU funding and support for breakthrough innovation projects with a market-creating potential as part of the enhanced European Innovation Council (EIC) pilot.

VisionHealth develops Kata®, the first digital educational and medical companion to enhance inhaler usage and drug delivery to the lungs. Throughout Kata’s further roadmap, the aim is to build a tailored solution for patients with CRD into the market, which will improve patient’s health outcome. In addition, it will provide highly valuable insights to transform healthcare for all relevant stakeholders.

Dr. Sabine Häußermann, CEO of VisionHealth, stated: “We are very happy to have received the EU grant and to be considered as a highly innovative company. This, of course, motivates us to further develop Kata according to the patients’ needs and to benefit from the full potential of its inhaled therapy.”